The most active measures used before the war against infectious diseases can be divided into three groups: (1) vaccines; (2) serums, and (3) specific chemical substances. According, then, to the measures employed, we practiced vaccinotherapy, serotherapy or chemotherapy. In the last few years a new form of therapy has been developed which has been called proteosotherapy or proteintherapy, according as one gives a proteose as a protein foreign to the internal medium (blood and lymph) such as the casein of milk. The characteristic feature of this method is the administration of the protein or proteose by a channel which avoids the action of the digestive juices; that is to say, by a parenteral route, subcutaneous, intramuscular or intravenous. Permit me to present to you briefly my experience with proteosotherapy, which I believe I was the first to use.
FIRST USE IN NONINFECTIOUS DISEASES
I used it first successfully in the
NOLF P. PROTEOSOTHERAPY BY THE INTRAVENOUS METHOD. JAMA. 1919;73(21):1579–1580. doi:10.1001/jama.1919.02610470015005
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: